Skip to main content
Global Edition
Sunday, May 5, 2024

Ehlers–Danlos syndromes

News and Video Search Results

News coverage

Aytu BioPharma Announces Formation of New Scientific Advisory Board to Support Development of AR101 for Vascular Ehlers-Danlos Syndrome

Aytu BioPharma Announces Formation of New Scientific Advisory Board to Support Development of AR101 for Vascular Ehlers-Danlos Syndrome

Accesswire
Aytu BioPharma Adds Late-Stage Pediatric Onset Rare Disease Asset to Development Pipeline from Rumpus Therapeutics

Aytu BioPharma Adds Late-Stage Pediatric Onset Rare Disease Asset to Development Pipeline from Rumpus Therapeutics

Accesswire

Metrodora Foundation Announces New Scientific Advisory Board

Accesswire

You might like